You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 140 No. 11, November 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  The Cutting Edge: Challenges in Medical and Surgical Therapeutics
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (31)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Dermatologic Procedures
 •Phototherapy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

UV-A1 Phototherapy Improves Nephrogenic Fibrosing Dermopathy

Reza Kafi, MD; Gary J. Fisher, PhD; Taihao Quan, PhD; Yuan Shao, PhD; Rui Wang; John J. Voorhees, MD; Sewon Kang, MD
From the University of Michigan Medical Center, Ann Arbor.

Arch Dermatol. 2004;140:1322-1324.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

REPORT OF A CASE

A 47-year-old woman presented with a 2-month history of progressive tightening of the skin on her legs. The tightening of her skin had begun 2 weeks after she was hospitalized for acute renal failure precipitated by therapy with nonsteroidal anti-inflammatory drugs. She had no history of renal disease or medical conditions that would predispose her to the organ failure. During her hospitalization, she was treated with supportive therapy only and did not require hemodialysis or peritoneal dialysis. Her renal function normalized, but the skin fibrosis continued to worsen. We initially examined her approximately 2 months after the onset of her skin disease. At the time, she had orange-red indurated plaques on both thighs and the lower part of her legs. The range of motion of her knees was . . . [Full Text of this Article]

THERAPEUTIC CHALLENGE

SOLUTION

LABORATORY METHODS

HYDROXYPROLINE MEASUREMENT

RNA ISOLATION AND QUANTITATIVE REAL-TIME REVERSE TRANSCRIPTASE–PCR

COMMENT

AUTHOR INFORMATION



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

UV-A1 Therapy for Nephrogenic Systemic Fibrosis
Tran et al.
Arch Dermatol 2009;145:1170-1174.
ABSTRACT | FULL TEXT  

Estimates of Risk, Empirical Treatment Observations, and Unexpected Laboratory Findings Reveal the Complexity of Nephrogenic Systemic Fibrosis
High
Arch Dermatol 2009;145:1178-1182.
FULL TEXT  

Limited Effects of UV-A1 Phototherapy in 3 Patients With Nephrogenic Systemic Fibrosis
Kreuter et al.
Arch Dermatol 2008;144:1527-1529.
FULL TEXT  

Gadolinium-enhanced MR Imaging and Nephrogenic Systemic Fibrosis: Retrospective Study of a Renal Replacement Therapy Cohort
Collidge et al.
Radiology 2007;245:168-175.
ABSTRACT | FULL TEXT  

The case for ultraviolet light therapy in nephrogenic fibrosing dermopathy--report of two cases and review of the literature
Wahba et al.
Nephrol Dial Transplant 2007;22:631-636.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.